Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RaPiCCa: PET/MRI for Cervical Cancer RT Planning
NCT03655977Unknown
- Sponsor
- Rigshospitalet
- Start
- Sep 2018
- Primary completion
- Sep 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label trial of 68Ga-NODAGA-E(c[RGDyK])2 in Cervical Cancer (CC), sponsored by Rigshospitalet. Primary endpoint: Feasibility of PET/MRI in radiation treatment planning workflow at 1 year. Status: unknown.
02
Drugs
68Ga-NODAGA-E(c[RGDyK])2
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT03655977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03655977.